Location History:
- Berlin, GB (2003)
- Berlin, DE (2002 - 2006)
Company Filing History:
2 out of 90 
1 out of 15,475 
1 out of 1 Years Active: 2002-2006
Title: The Innovative Contributions of Peter Henklein
Introduction
Peter Henklein is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of virology, particularly in the development of methods and compounds for treating lentiviral infections. With a total of 4 patents, Henklein's work is at the forefront of scientific innovation.
Latest Patents
Henklein's latest patents focus on methods for identifying agents that inhibit lentivirus replication. One of his inventions provides screening methods for identifying compounds that induce the loss of the lentiviral protein Vpr. Additionally, he has developed methods for inhibiting the peptidyl-prolyl cis/trans isomerase (PPIase) activity of proteins that catalyze the isomerization of cis-peptidylprolyl bonds in Vpr. These compounds are crucial for treating lentiviral infections. His work also includes synthetic peptides derived from the viral regulatory protein R (Vpr) of HIV-1, which are used in biological assays and the development of anti-Vpr antibodies.
Career Highlights
Throughout his career, Peter Henklein has worked with prestigious institutions such as the J. David Gladstone Institutes and the University of California. His research has significantly advanced the understanding of lentiviral mechanisms and potential therapeutic approaches.
Collaborations
Henklein has collaborated with esteemed colleagues, including Ulrich Schubert and Michael P. Sherman. These partnerships have further enriched his research and contributed to the scientific community's knowledge of virology.
Conclusion
Peter Henklein's innovative work in the field of virology has led to important advancements in the treatment of lentiviral infections. His contributions continue to impact the scientific community and pave the way for future research.